Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 67296-2288

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 67296-2288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A Kaplan-Meier cumulative incidence curve comparing Rosuvastatin Calcium (Rosuva) to placebo over 5 years. The graph shows cumulative incidence percentage on the y-axis and years on the x-axis. Rosuvastatin displays a lower cumulative incidence than placebo, with hazard ratio (HR) 0.56 and P value <0.001. Numbers at risk for each time point are shown below the x-axis.*

FDA Label Image

Figure2 (Image 01)

A forest plot chart comparing the number of events and hazard ratios for various cardiovascular endpoints between Rosuvastatin Calcium 20 mg and placebo groups. The endpoints include primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), hospitalized unstable angina, and arterial revascularization. The plot displays hazard ratios with 95% confidence intervals and P-values for each endpoint, visualized by dots and horizontal lines on a logarithmic scale from 0.1 to 10.*

FDA Label Image

Figure3 (Image 02)

A box plot chart showing percent change from baseline in LDL-C for four statin drugs: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin at varying doses. The x-axis shows drug names and doses in mg, and the y-axis shows percent change from 0 to -75%. Data distributions are displayed as box plots with different shading by drug.*

FDA Label Image

Lbl10mg90s (Lbl10mg90s)

Label for Rosuvastatin Tablets USP 10 mg, film-coated tablets in a 90-tablet package. The label includes the NDC 16714-989-01, manufacturer Glenmark Pharmaceuticals Ltd., and distributor Northstar Rx LLC in Memphis, TN. Storage and handling instructions, barcode, and regulatory information are also visible.*

FDA Label Image

Lbl20mg90s (Lbl20mg90s)

Label for Rosuvastatin Tablets USP 20 mg film-coated oral tablets in a 90-tablet package. The label includes storage instructions, manufacturer details (Glenmark Pharmaceuticals Ltd., India), and distributor information (Northstar Rx LLC). A barcode and warning to keep out of reach of children are also visible.*

FDA Label Image

Lbl40mg30s (Lbl40mg30s)

Rosuvastatin Tablets USP 40 mg film-coated tablet label. The label states it contains 30 tablets and includes storage instructions and warnings. Manufactured by Glenmark Pharmaceuticals Ltd. in India and repackaged by Northstar Rx LLC, Memphis, TN. It features a barcode and the NorthStar logo with NDC 16714-991-01.*

FDA Label Image

Lbl5mg90s (Lbl5mg90s)

Label for Rosuvastatin Tablets USP 5 mg, film-coated tablets, package of 90 tablets. The label includes dosage strength, storage instructions, warning to keep out of reach of children, manufacturer Glenmark Pharmaceuticals Ltd., and marketing authorization holder Northstar Rx LLC, Memphis, TN. The product is marked Rx only and notes it is made in India.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Rosuvastatin Calcium, showing its molecular composition and arrangement, including a calcium ion (Ca2+) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.